https://www.selleckchem.com/pr....oducts/bsj-4-116.htm
8% of patients with HBV RNA levels1000copies/mL (P0.001). More patients with HBV RNA levels 1000 copies/mL at end of treatment achieved loss of hepatitis B surface antigen than patients with higher levels (30.9% vs 1.6%; P=0.027). The HBV RNA level at end of treatment predicted biochemical relapse after treatment discontinuation and may be used to guide decisions on treatment discontinuation. The HBV RNA level at end of treatment predicted biochemical relapse after treatment discontinuation and may be used to guide decisio
Like
Comment
Share
